GoodRx (GDRX)
(Delayed Data from NSDQ)
$7.19 USD
+0.11 (1.55%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $7.24 +0.05 (0.70%) 7:58 PM ET
2-Buy of 5 2
C Value C Growth F Momentum D VGM
Industry / Sector Report
Industry : Medical Services
Zacks Industry Rank
Top 32% (81 out of 252)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.11 | 1.51 | 9.99 |
Current Quarter Estimate | 0.09 | 1.48 | 60.00 |
Year Ago Quarter Estimate | 0.07 | 0.51 | 52.54 |
Next Quarter Estimate | 0.11 | 1.51 | 61.00 |
Next Year Estimate | 0.48 | 8.09 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 42.86 | 12.50 | 17.08 |
Next Year | 20.00 | 20.90 | 8.00 |
Last 5 Years | NA | 9.50 | 8.10 |
Next 5 Years | 7.90 | 14.90 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 25.68 | 17.34 |
Price/Book (MRQ) | 3.72 | 1.84 |
Price/Cash Flow (MRFY) | 17.42 | 12.17 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -1.18% | 3.64% |
Return on Equity (TTM) | 2.45% | 6.91% |
Debt to Equity (MRQ) | NA | 32.56 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.